UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Details
Sales, net	$ 8,787	$ 11,846	$ 19,689	$ 22,579
Cost of goods sold	3,837	4,346	7,903	8,306
Gross profit	4,950	7,500	11,786	14,273
Operating expense
Selling, general and administrative	2,857	2,906	5,696	5,463
Research & development	116	113	250	228
Total operating expenses	2,973	3,019	5,946	5,691
Operating income	1,977	4,481	5,840	8,582
Other income	0	84	125	120
Income before provision for income taxes	1,977	4,565	5,965	8,702
Provision for income taxes	664	1,040	1,513	2,038
Net income	$ 1,313	$ 3,525	$ 4,452	$ 6,664
Earnings per common share (basic)	$ 0.36	$ 0.95	$ 1.21	$ 1.79
Earnings per common share (diluted)	$ 0.36	$ 0.94	$ 1.21	$ 1.78
Shares outstanding - basic	3,643	3,721	3,675	3,721
Shares outstanding - diluted	3,659	3,735	3,690	3,737
Other comprehensive income (loss):
Foreign currency translation net of taxes of $0 in all periods	$ 522	$ (464)	$ (1,927)	$ 484
Total comprehensive income	$ 1,835	$ 3,061	$ 2,525	$ 7,148